These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35465470)

  • 1. Clinicopathological Features of Papillary Renal Cell Carcinoma With Venous Tumor Thrombus: Case Series from a Large Chinese Center.
    Liu Z; Ge L; Zhao X; Lu M; Aili A; Li Y; Zhu G; Hong P; Tian X; Wang S; Zhang H; Liu C; Ding Z; Zhang S; Ma L
    Clin Med Insights Oncol; 2022; 16():11795549221092217. PubMed ID: 35465470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A single-center experience.
    Wang T; Huang Y; Yang L; Yang Y; Li D; Zhang X; Ding X; Wang B; Ma X
    Front Oncol; 2022; 12():980564. PubMed ID: 36132138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
    Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study.
    Fleury R; Bertail T; Bensalah K; Bernhard JC; Audenet F; Waeckel T; Parier B; Champy C; Olivier J; Doumerc N; Tricard T; Branger N; Bruyere F; Neuville P; Surlemont L; Alexandre Long J; Fontenil A; Vallee M; Roupret M; Boissier R; Jacques Patard J; Durand M; Ouzaid I; Rouget B; Durand X; Joncour C; Belas O; Denise Gomez F; Bigot P; Khene ZE;
    Eur Urol Open Sci; 2024 Apr; 62():123-130. PubMed ID: 38496822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy.
    Riveros C; Ranganathan S; Xu J; Chang C; Kaushik D; Morgan M; Miles BJ; Muhammad T; Anis M; Aghazadeh M; Zhang J; Efstathiou E; Klaassen Z; Brooks MA; Rini B; Wallis CJD; Satkunasivam R
    Urol Oncol; 2023 Mar; 41(3):150.e1-150.e9. PubMed ID: 36610815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.
    Chen F; Huhdanpaa H; Desai B; Hwang D; Cen S; Sherrod A; Bernhard JC; Desai M; Gill I; Duddalwar V
    Springerplus; 2015; 4():66. PubMed ID: 25694862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.
    Liu Z; Li Y; Zhao X; Ge L; Zhu G; Hong P; Tang S; Zhang S; Tian X; Wang S; Liu C; Zhang H; Ma L
    BMC Surg; 2021 Dec; 21(1):443. PubMed ID: 34963464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study.
    Li S; Liu X; Chen X
    J Cancer; 2022; 13(4):1193-1202. PubMed ID: 35281881
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.
    Vergho DC; Kneitz S; Kalogirou C; Burger M; Krebs M; Rosenwald A; Spahn M; Löser A; Kocot A; Riedmiller H; Kneitz B
    PLoS One; 2014; 9(10):e109877. PubMed ID: 25279769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinicopathological Features and Prognosis in Patients With Papillary Renal Cell Carcinoma: A Multicenter Retrospective Study in Chinese Population.
    Hong B; Hou H; Chen L; Li Z; Zhang Z; Zhao Q; Du X; Li Y; Ye X; Xu W; Liu M; Zhang N
    Front Oncol; 2021; 11():753690. PubMed ID: 34621685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience.
    Liu Z; Tang S; Tian X; Zhang H; Wang G; Zhang S; Ma L
    BMC Cancer; 2020 Jan; 20(1):61. PubMed ID: 31992244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
    Büttner FA; Winter S; Stühler V; Rausch S; Hennenlotter J; Füssel S; Zastrow S; Meinhardt M; Toma M; Jerónimo C; Henrique R; Miranda-Gonçalves V; Kröger N; Ribback S; Hartmann A; Agaimy A; Stöhr C; Polifka I; Fend F; Scharpf M; Comperat E; Wasinger G; Moch H; Stenzl A; Gerlinger M; Bedke J; Schwab M; Schaeffeler E
    Genome Med; 2022 Sep; 14(1):105. PubMed ID: 36109798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
    Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
    PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
    Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
    Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma.
    Takahashi H; Vikram R; Jimenez RE; Bolan CW; Kawashima A; Karam JA; Takahashi N
    Abdom Radiol (NY); 2021 Nov; 46(11):5250-5259. PubMed ID: 34338814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.